Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AK Other drugs for treatment of tuberculosis
J04AK05 Bedaquiline
D09873 Bedaquiline fumarate (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Antimycobacterials
Antituberculars
Bedaquiline
D09873 Bedaquiline fumarate (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
622 Tuberculosis preparations
6222 Isoniazids
D09873 Bedaquiline fumarate (JAN/USAN)
Drug groups [BR:br08330]
Antibacterial
DG01966 Antitubercular
DG00644 Bedaquiline
D09873 Bedaquiline fumarate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00644 Bedaquiline
D09873 Bedaquiline fumarate
Antimicrobials [BR:br08307]
Antibacterials
Other antibacterials
Membrane-bound ATP synthase inhibitor
D09873 Bedaquiline fumarate (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09873
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09873
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09873
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09873
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09873
Drug groups [BR:br08330]
Antibacterial
DG01966 Antitubercular
DG00644 Bedaquiline
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00644 Bedaquiline
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Other antibacterials
Membrane-bound ATP synthase inhibitor
DG00644 Bedaquiline